Fulgent Genetics (FLGT) Non Operating Income (2015 - 2026)

Fulgent Genetics has reported Non Operating Income for 9 years, with the latest figure at $6.4 million in Q2 2026.

• Quarterly Non Operating Income rose 453.43% year-over-year to $6.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $29.8 million (up 131.2% YoY) and the FY2025 annual result came in at $21.1 million, down 4.06% from the prior year.
• Non Operating Income slipped to $6.4 million in Q2 2026 per FLGT's latest filing, from $8.6 million in the prior quarter.
• Over five years, Non Operating Income peaked at $8.6 million in Q1 2026 and troughed at -$1.8 million in Q2 2025.
• A 4-year average of $5.9 million and a median of $7.3 million in 2024 frame the typical range for Non Operating Income.
• The widest YoY moves for Non Operating Income: up 639.64% in 2025, down 123.48% in 2025.
• Over 4 years, Non Operating Income stood at $5.9 million in 2023, then surged by 36.54% to $8.1 million in 2024, then slipped by 13.92% to $7.0 million in 2025, then retreated by 8.34% to $6.4 million in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered $6.4 million, $8.6 million, and $7.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.